Interim analysis of cytarabine (ara-C) and cladribine (2-CDA) combination therapy in acute myeloid leukemia (AML).

被引：0
|
作者：
Radomski, KM
Gandhi, V
Srivastava, DK
Razzouk, BI
Behm, FG
Plunkett, W
Pui, CH
Rubnitz, JE
Ribeiro, RC
机构：
[1] St Jude Childrens Res Hosp, Memphis, TN 38105 USA
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1411
引用
收藏
页码：327A / 327A
页数：1
相关论文
共 50 条
  • [31] Association between 2-CdA and Ara-C as a rescue for pediatric patients with LCH, hematological dysfunction and failure to standard therapy
    Bernard, F
    Thomas, C
    Chiron, R
    Bertrand, Y
    Munzer, M
    Parker, JL
    Pellegrino, B
    Ouache, M
    Perel, Y
    Chastagner, P
    Vermylen, C
    Donadieu, J
    PEDIATRIC BLOOD & CANCER, 2004, 43 (02) : 198 - 198
  • [32] Induction Treatment of Acute Myeloid Leukemia in an Elderly Patient With Intra-marrow Injection of Cytarabine (Ara-C)
    Islam, Anwarul
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S293 - S293
  • [33] CYTOSINE-ARABINOSIDE (ARA-C) IN INTERMEDIATE DOSES (IDAC) AS THERAPY FOR PATIENTS (PTS) WITH ACUTE MYELOID-LEUKEMIA (AML)
    ESTEY, EH
    PLUNKETT, WK
    KEATING, MJ
    MCCREDIE, KB
    FREIREICH, EJ
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 209 - 209
  • [34] Distinct Proteomic Signaling Networks Stratify Responses to Ara-C Based Induction Therapy in Patients with Acute Myeloid Leukemia (AML).
    Minden, Mark
    Rosen, David
    Putta, Santosh
    Cohen, Aileen
    Francis-Lang, Helen
    Covey, Todd
    Woronicz, John
    Soper, David
    Long, Brian
    Cordeiro, James
    Panganiban-Lustan, Lootsie
    Banville, Steve
    Gayko, Urte
    Cesano, Alessandra
    Fantl, Wendy
    BLOOD, 2008, 112 (11) : 885 - 886
  • [35] Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trial
    J E Rubnitz
    K R Crews
    S Pounds
    S Yang
    D Campana
    V V Gandhi
    S C Raimondi
    J R Downing
    B I Razzouk
    C-H Pui
    R C Ribeiro
    Leukemia, 2009, 23 : 1410 - 1416
  • [36] Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trial
    Rubnitz, J. E.
    Crews, K. R.
    Pounds, S.
    Yang, S.
    Campana, D.
    Gandhi, V. V.
    Raimondi, S. C.
    Downing, J. R.
    Razzouk, B. I.
    Pui, C-H
    Ribeiro, R. C.
    LEUKEMIA, 2009, 23 (08) : 1410 - 1416
  • [37] A phase I/II study of idarubicin (Ida) with continuous infusion fludarabine (F-ara-A) and cytarabine (ara-C) for refractory or recurrent pediatric acute myeloid leukemia (AML)
    Leahey, A
    Kelly, K
    Rorke, LB
    Lange, B
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1997, 19 (04) : 304 - 308
  • [38] Efficacy of topoisomerase I and II inhibitors in combination with standard chemotherapeutic agents (Ara-C and daunorubicin) in the management of acute myeloid leukemia (AML).
    Saba, HI
    Sullivan, DM
    Loughran, TP
    Moscinski, LC
    Sullivan, PA
    Morelli, GA
    BLOOD, 2003, 102 (11) : 261B - 261B
  • [39] ETOPOSIDE (VP-16) AND CYTOSINE-ARABINOSIDE (ARA-C) COMBINATION FOR SECONDARY AND RELAPSED ACUTE MYELOID-LEUKEMIA (AML)
    LAZZARINO, M
    MORRA, E
    INVERARDI, D
    ALESSANDRINO, EP
    BERNASCONI, P
    MERANTE, S
    BERNASCONI, C
    LEUKEMIA RESEARCH, 1986, 10 (01) : 111 - 111
  • [40] Phase II Study of Cladribine, Idarubicin, and Cytarabine (araC) in Patients with Acute Myeloid Leukemia (AML)
    Kadia, Tapan
    Cortes, Jorge E.
    Jabbour, Elias J.
    Daver, Naval
    Pemmaraju, Naveen
    Ravandi, Farhad
    Jain, Nitin
    Verstovsek, Srdan
    DiNardo, Courtney
    Alvarado, Yesid
    Ferrajoli, Alessandra
    Burger, Jan A.
    Garcia-Manero, Guillermo
    Ohanian, Maro
    Konopleva, Marina
    Estrov, Zeev
    Wierda, William
    Brandt, Mark
    Fitch, Tina
    Borthakur, Gautam
    Kantarjian, Hagop M.
    BLOOD, 2015, 126 (23)
12345